| Accession |
PRJCA038837 |
| Title |
Metabolic reprogramming in HER2 positive breast cancer |
| Relevance |
Medical |
| Data types |
Whole genome sequencing
Epigenomics
Transcriptome or Gene expression
Metabonomics
|
| Organisms |
Homo sapiens
|
| Description |
This multi-omics cohort of HER2 positive breast cancer includes metabolomics, transcriptomics and epigenomics data. |
| Sample scope |
Monoisolate |
| Release date |
2025-04-16 |
| Publication |
| PubMed ID |
Article title |
Journal name |
DOI |
Year |
| 40464376
|
Targeting SLC7A11-mediated cysteine metabolism for the treatment of trastuzumab-resistant HER2-positive breast cancer eLife Assessment Reviewer #1 (Public review): Reviewer #2 (Public review): Author response
|
eLife
|
10.7554/eLife.103953
|
2025
|
|
|
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
Yongmei
Yin (ymyin@njmu.edu.cn)
|
| Organization |
The First Affiliated Hospital of Nanjing Medical University |
| Submission date |
2025-04-16 |
